Leil Storage announces the release of SaunaFS 5.0, redefining what’s possible for on-premise large-scale enterprise storage empowered by hyperscale efficiency. SaunaFS 5.0 is the industry's first ...

ALK (ALKB:DC / OMX: ALK B) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of the company’s tree pollen tablet ITULAZAX® for the treatment in ...

On July 19, the 35th Grassland Naadam Fair of the Inner Mongolia Autonomous Region kicked off in Xilinhot, Xilingol League, welcoming over 100,000 visitors from across China alongside local residents ...

Readers of the international Travel and Leisure magazine voted Helsinki Airport among the top ten airports in the world in July 2025. Helsinki Airport is the only European airport to reach a top spot ...

Wolters Kluwer Financial & Corporate Compliance (FCC) announces today that it has signed a binding agreement to sell its Finance, Risk and Regulatory Reporting (FRR) unit to Regnology Group GmbH ...

European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Approval is based on ...

BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that the combined market value of its ...

The strong performance of the G Series on Prime Day underscores KOORUI  ’s commitment to delivering thoughtful design and ...

Mirdametinib is marketed under the brand name EZMEKLY® in the European Union and is conditionally approved by the European ...

NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) -- Chinese imaging gear brand Ulanzi  has been recognized by global research firm Frost & Sullivan as the No. 1 camera-accessories brand worldwide by sales ...

The fourth TERA-Award is supported by the Hong Kong Investment Corporation, InvestHK, the UK’s Department for Business and Trade and Kerogen CelerateX, reflecting a growing commitment to accelerate ...

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of next-generation, Targeted Protein Degradation (TPD) medicines, today announces the successful achievement of a ...